Abstract
To truly understand cerebellar function, it is essential to address the effect of the numerous peptides present within cerebellar circuits and the role they play in modulating neuronal activity in the cerebellum. To date, at least 22 neuropeptides have been identified in the cerebellum. However, relatively little is conclusively known about the modulatory role of the vast majority of these peptides. The potential role of three peptides is reviewed. Future research should focus on defining transduction pathways activated following binding of these peptides to their G-protein-coupled receptors, defining the function of peptides produced by cerebellar neurons such as Purkinje cells or Golgi cells, and describing how neuropeptides modulate cerebellar nuclear neurons, which represent the output of the cerebellum.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
- Cerebellar nuclei
- Climbing fiber
- Corticotropin releasing factor
- orexin
- Calcitonin gene related peptide
- Purkinje cell
1 Introduction
The existence of neuropeptides in the central nervous system has been known since the 1970s (Hokfelt 1991). Today, at least 100 neuropeptides have been identified (Ito 2009). Neuropeptides are polypeptides that almost exclusively bind to G-protein coupled receptors. Thus, their actions require activation of second messenger pathways, which utilize complex intracellular pathways to alter the response properties of neurons. Neuropeptides are often characterized as neuromodulators.
An overview of neuropeptide synthesis, transport, release and removal may be found in a neuropharmacology textbook. A unique feature of neuropeptide synthesis is that it occurs entirely within the cell bodies of neurons and requires active transport to an axon terminal. Further, a single gene may produce several different related neuropeptides in different brain regions. Within the presynaptic terminal, large dense core vesicles that contain neuropeptides tend to be located away from the active zone. The mechanism of peptide release is the same as for vesicles containing amino acids, requiring influx of calcium. However, for peptides to be released, more calcium influx is required than that needed for release of amino acid neurotransmitters. One way to accomplish this by a longer train of action potentials coming down the axon. Whereas a single action potential may result in release of amino acids, a prolonged train may be required to allow greater influx of calcium and subsequent release of peptides into the synaptic cleft. Thus peptide release, is activity dependent.
The method for terminating peptide activity is through endopeptidases and exopeptidases. The concentration of these peptidases is relatively low so neuropeptides may diffuse great distances from the site of their release to remote receptors thus giving them the opportunity to effect larger populations of neurons.
3 Role of Peptides in the Cerebellum
One of the major challenges to understanding of the role for peptides in the cerebellum is the fact that their distribution varies between and within species. This chapter will describe some of the potential roles for three peptides in regulating cerebellar circuitry.
3.1 Corticotropin Releasing Factor (CRF)
CRF is present in climbing and mossy fiber afferent systems in all mammalian species studied to date (Fig. 35.1a, b). CRF in climbing fibers originates from neurons in the inferior olive whereas CRF in mossy fibers originates from the vestibular complex and the reticular formation (Errico and Barmack 1993; Bishop 1998). Neurophysiological studies have shown that CRF is essential in the generation of long-term depression, a mechanism associated with cerebellar learning (Miyata and Ito 1999). Further, CRF has been shown to increase the firing rate of Purkinje cells (Fig. 35.1c, d) by decreasing the amplitude and duration of the after hyperpolarizing potential (Fox and Gruol 1993) and blocking GABA induced inhibition (Bishop 1990) (Fig. 35.1e).
3.2 Orexin
Orexin is present in a beaded plexus of axons that originate from neurons located in the perifornical area and the lateral hypothalamus (Zhang et al. 2013). These axons terminate primarily within the flocculus of the cerebellum (Nisimaru et al. 2013). Zhang et al. (2013) suggested that the orexinergic system participates in motor control and integration of somatic motor and non-somatic (e.g., visceral, emotional) systems. They postulated that a somatic-non-somatic integration was critical for generation of a coordinated behavioral response to changes in the internal and external environment. The primary effect of orexin was on neurons located in the vestibular nuclei and the cerebellar interpositus nucleus (Yu et al. 2010) which represent a peptidergic effect on the output neurons of the cerebellum and closely related vestibular system.
3.3 Calcitonin Gene Related Peptide (CGRP)
CGRP is transiently expressed in climbing fibers during rodent development (Morara et al. 1992). The CGRP receptor, which mediates the effect of this peptide, is present on astrocytes during early stages of development and on Purkinje cells at later stages (Morara et al. 2008). Studies demonstrate that CGRP modulates calcium in astrocytes during development (Morara et al. 2008). During later stages of development, CGRP was shown to stimulate Purkinje cell dendrite growth in culture (D’Antoni et al. 2010), an effect that was dependent on activation of CGRP receptors on astrocytes.
A different pattern of CGRP expression was observed in the cat’s cerebellum, compared to the rat’s, consistent with unique distributions and functions of peptides in different species. In the cat (Bishop 1992), CGRP was found in mossy fibers in the adult animal. Physiological studies demonstrated that CGRP suppressed spontaneous and excitatory amino acid-induced activity (Bishop 1995). In addition, there was a heterogeneous distribution of CGRP mossy fibers in the cat’s cerebellum suggesting that the effect of this peptide is restricted to specific populations of cerebellar neurons (Bishop 1992).
4 Conclusion and Future Directions
To truly understand cerebellar function, it is essential to understand the functional role of the numerous peptides present within cerebellar circuits. Likely, many of the peptides expressed in the cerebellum are involved in modulating the activity of Purkinje cells and one, CRF, is essential for generation of long-term depression in the cerebellar cortex. However, to date, relatively little is conclusively known about the modulatory role of the vast majority of these peptides on intact cerebellar circuits. Functionally, it is essential to identify specific second messenger and associated signal transduction pathways and to determine differential roles for peptides during different stages of development and in the adult. Finally, defining the role of neuropeptides in regulating the activity of cerebellar nuclear neurons, which represent the output of the cerebellum, is essential.
References
Bishop GA (1990) Neuromodulatory effects of corticotropin releasing factor on cerebellar Purkinje cells: an in vivo study in the cat. Neuroscience 39:251–257
Bishop GA (1992) Calcitonin gene related peptide in cerebellar afferents: distribution and origin. J Comp Neurol 322:201–212
Bishop GA (1995) Calcitonin gene related peptide modulates neuronal activity in the mammalian cerebellar cortex. Neuropeptides 28:85–97
Bishop GA (1998) Brainstem origin of corticotropin releasing factor afferents to the nucleus interpositus anterior of the cat. J Chem Neuroanat 15:134–153
D’Antoni S, Zambusi L, Codazzi F, Zacchetti D, Grohovaz F, Provini L, Catania MV, Morara S (2010) Calcitonin gene-related peptide (CGRP) stimulates Purkinje cell dendrite growth in culture. Neurochem Res 35:2135–2143
Errico P, Barmack NH (1993) Origins of cerebellar mossy and climbing fibers immunoreactive for corticotropin-releasing factor in the rabbit. J Comp Neurol 336:307–320
Fox EA, Gruol DL (1993) Corticotropin-releasing factor suppresses the after hyperpolarization in cerebellar Purkinje neurons. Neurosci Lett 149:103–107
Hokfelt T (1991) Neuropeptides in perspective: the last ten years. Neuron 7:867–879
Ito M (2009) Functional roles of neuropeptides in cerebellar circuits. Neuroscience 162:666–672
Miyata M, Ito M (1999) Corticotropin-releasing factor plays a permissive role in cerebellar long-term depression. Neuron 22:763–775
Morara S, Rosina A, Provini L (1992) CGRP as a marker of the climbing fibers during the development of the cerebellum in the rat. Ann NY Acad Sci 657:461–463
Morara S, Wang LP, Filippov V, Dickerson IM, Grohovaz F, Provini L, Kettenmann H (2008) Calcitonin gene-related peptide (CGRP) triggers Ca2+ responses in cultured astrocytes and in Bergmann glial cells from cerebellar slices. Eur J Neurosci 28:2213–2220
Nisimaru N, Mittal C, Shirai Y, Sooksawate T, Anandaraj P, Hashikawa T, Nagao S, Arata A, Sakurai T, Yamamoto M, Ito M (2013) Orexin-neuromodulated cerebellar circuit controls redistribution of arterial blood flows for defense behavior in rabbits. Proc Natl Acad Sci U S A 110:14124–14131
Yu L, Zhang XY, Zhang J, Zhu JN, Wang JJ (2010) Orexins excite neurons of the rat cerebellar nucleus interpositus via orexin 2 receptors in vitro. Cerebellum 9:88–95
Zhang XY, Yu L, Zhuang QX, Zhang J, Zhu JN, Wang JJ (2013) Hypothalamic histaminergic and orexinergic modulation on cerebellar and vestibular motor control. Cerebellum 12:294–296
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Bishop, G.A., King, J.S. (2016). Neuropeptides in the Cerebellum. In: Gruol, D., Koibuchi, N., Manto, M., Molinari, M., Schmahmann, J., Shen, Y. (eds) Essentials of Cerebellum and Cerebellar Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-24551-5_35
Download citation
DOI: https://doi.org/10.1007/978-3-319-24551-5_35
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-24549-2
Online ISBN: 978-3-319-24551-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)